Search Results

Keywords: tilray

Week in Review: Vermont OKs adult-use marijuana, Maine sales begin, WHO plan questioned & more

Vermont became the 11th state in the U.S. to fully legalize marijuana for adult use when Republican Gov. Phil Scott let a bill to allow recreational sales become law without his signature. MJBizDaily takeaway: Setting aside the governor’s half-hearted support, the cannabis industry can be content that Scott didn’t veto the bill the way former […]

Read More

Aphria joins crowded German cannabis flower market; sales to start in ‘weeks’

Canadian cannabis producer Aphria is joining the increasingly competitive German medical marijuana flower market. The company said this week it completed its first shipment of dried flower to its wholly owned German subsidiary, CC Pharma GmbH. Hendrik Knopp, managing director of Aphria Germany, told Marijuana Business Daily the company expects to have products available for […]

Read More

Uruguay-grown medical cannabis available in Germany for first time

Medical cannabis flower grown in Uruguay recently became available in the German market for the first time. The news sheds light on the final destination of large exports quietly shipped from Uruguay to Portugal at the end of 2019 and earlier this year, as first reported by Marijuana Business Daily. The shipments’ final destinations were […]

Read More

Insurance-covered medical cannabis falls for the first time in Germany

Insurance reimbursements for cannabis in Germany dropped for the first time – on a quarterly basis – since the current medical program started in early 2017, according to new data for the quarter ended June 30, 2020. The reason: Prices fell while the number of prescriptions barely grew. This is consistent with Marijuana Business Daily’s […]

Read More

New medical cannabis product recall in Germany

Cologne, Germany-based Cannamedical is recalling a batch of cannabis flower after contamination above acceptable levels was detected, Marijuana Business Daily has learned. This is at least the third cannabis recall this summer in Germany. Previously, Tilray recalled some cannabis extracts. “On Tuesday, Cannamedical voluntarily started a recall of one batch of flower of our ‘Sativa’ […]

Read More

Cannabis companies secure fresh funding deals as investors wade back into capital markets

Marijuana businesses have raised hundreds of millions of dollars in recent months, a trend that is expected to continue as an investment dry spell that began late last year appears to be easing. Investors have shown renewed interest in U.S. cannabis companies after they were designated “essential” businesses during the coronavirus pandemic by most states, […]

Read More

18 trends shaping Canada’s recreational marijuana market

Canada’s adult-use cannabis market has expanded rapidly since the legalization of marijuana in October 2018. Monthly retail sales figures in May signaled an annual market worth around $1.6 billion (CA$2.2 billion)—or roughly the size of Colorado’s recreational and medical markets combined. But since the population in Canada is more than six times larger than Colorado’s, […]

Read More

Global Retreat: Canadian cannabis firms pull back global aspirations

Back in the early days of Canada’s regulated adult-use cannabis industry, some of the country’s biggest publicly traded marijuana producers discovered that investors rewarded international ambitions. The domestic recreational marijuana market that launched in October 2018 was exciting, of course, but that opportunity would always be limited by Canada’s relatively small population of around 38 […]

Read More

Clever Leaves obtains cannabis cultivation license in Portugal

Clever Leaves, a multinational cannabis company with its main operations in Colombia, said Thursday it obtained a “license to cultivate, sell and export medical cannabis” in Portugal. Clever Leaves said the license it received from Infarmed – the Portuguese health authority – is “provisional” because the facility has not been physically inspected because of the […]

Read More

US marijuana companies outperform Canada’s to erase discount in second-quarter earnings season

The stocks of U.S.-focused operators have rallied while Canada-focused operators have underperformed in the second-quarter earnings season, closing the valuation gap on enterprise value-to-2021 sales.  The rally in the United States bodes well for the thawing of the capital markets for U.S. operators – at least for those that can show strong and profitable revenue […]

Read More